Speaker illustration

Doctor William Parker

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

Clinical Lecturer and Specialist Registrar in Cardiology, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. Research interests in antithrombotic therapy and other aspects of vascular prevention.

Does deactivation of a site's surgical cardiac transplant program affect the long-term survival of its recipients?

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Heart Transplantation

Session: Chronic Heart Failure – Treatment

Thumbnail

Ultra-low-dose twice-daily aspirin improves haemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes: Antiplatelet Agents

Session: Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis

Thumbnail

ESC 365 is supported by

logo Novo Nordisk